Effects of exercise-induced myokines on rehabilitation and metabolic regulation

Elif Zeynep Öztürk; Mehlika Alataş

doi:10.32322/jhsm.1883007

Effects of exercise-induced myokines on rehabilitation and metabolic regulation

Abstract

Recent research on exercise has introduced a new biological dimension by demonstrating that skeletal muscle functions not only as a mechanical structure but also as an endocrine organ. Myokines released from skeletal muscle during exercise play critical roles in metabolic regulation, inflammation control, nervous system function, and tissue regeneration. Consequently, growing research interest has focused on elucidating the biological and therapeutic significance of myokines. This review examines the effects of exercise-induced myokines on clinical rehabilitation and metabolic regulation, highlighting their therapeutic potential in neurological and cardiac rehabilitation as well as in the management of metabolic syndrome, while emphasizing the biological properties and functional roles of the most extensively studied myokines.

Keywords

References

Barbalho SM, Flato UAP, Tofano RJ, et al. Physical exercise and myokines: relationships with sarcopenia and cardiovascular complications. Int J Mol Sci. 2020;21(10):3607. doi:10.3390/ijms21103607
Qi C, Song X, Wang H, Yan Y, Liu B. The role of exercise-induced myokines in promoting angiogenesis. Front Physiol. 2022;13:981577. doi:10.3389/fphys.2022.981577
Severinsen MCK, Pedersen BK. Muscle–organ crosstalk: the emerging roles of myokines. Endocr Rev. 2020;41(4):594-609. doi:10.1210/endrev/bnaa016
Iglesias P. Muscle in endocrinology: from skeletal muscle hormone regulation to myokine secretion and its implications in endocrine-metabolic diseases. J Clin Med. 2025;14(13):4490. doi:10.3390/jcm1413 4490
Zhu M, Chen W, Zhang J. Aerobic exercise, an effective intervention for cognitive impairment after ischemic stroke. Front Aging Neurosci. 2025; 17:1514271. doi:10.3389/fnagi.2025.1514271
De Assis GG, Murawska-Ciałowicz E. Brain-derived neurotrophic factor and stroke: perspectives on exercise as a health care strategy. Hum Mov. 2024;25(1):1-14. doi:10.5114/hm.2024.136050
Jodeiri Farshbaf M, Alviña K. Multiple roles in neuroprotection for the exercise-derived myokine irisin. Front Aging Neurosci. 2021;13:649929. doi:10.3389/fnagi.2021.649929
Villamil-Parra W, Moscoso-Loaiza L. Effects of physical exercise on irisin and BDNF concentrations, and their relationship with cardiometabolic and mental health of individuals with metabolic syndrome: a systematic review. Exp Gerontol. 2024;198:112640. doi:10.1016/j.exger.2024.112640

Montero-Almagro G, Bernal-Utrera C, Geribaldi-Doldán N, Nunez-Abades P, Castro C, Rodriguez-Blanco C. Influence of high-intensity interval training on neuroplasticity markers in post-stroke patients: systematic review. J Clin Med. 2024;13(7):1985. doi:10.3390/jcm13071985
Grześkiewicz M, Kobak JE, Drewniak H, Terlecki P, Przywara S. Irisin-the future of ischemic stroke therapy? Acta Angiol. 2023;29(1):19-24. doi:10.5603/AA.2023.0006
Xiao W, Yang Y, Bai L, et al. Exercise-induced irisin ameliorates cognitive impairment following chronic cerebral hypoperfusion by suppressing neuroinflammation and hippocampal neuronal apoptosis. J Neuroinflammation. 2025;22(1):168. doi:10.1186/s12974-025-03493-5
Chen X, Zhang G, Liu M, He J, Zhang Z. New perspectives on molecular mechanisms underlying exercise-induced benefits in Parkinson disease. NPJ Parkinsons Dis. 2025;11(1):256. doi:10.1038/s41531-025-01113-w
Yani S, Harris S, Jusuf AA, Goenarjo R, Makkiyah FA, Sabita R, Ibrahim N. Effect of high-intensity interval training on BDNF level in ischemic stroke rat model on recovery of motor function. Indones Biomed J. 2024; 16(2):152-161.
Puoyan-Majd S, Parnow A, Rashno M, Heidarimoghadam R, Komaki A. Effects of pretreatment with coenzyme Q10 and high-intensity interval training on FNDC5, irisin, and BDNF levels and amyloid-beta plaque formation in hippocampus of Aβ-induced Alzheimer disease rats. CNS Neurosci Ther. 2025;31(2):e70221. doi:10.1111/cns.70221
Skrypnik D, Skrypnik K, Granell JC, Woszczyk D, Suliburska J. Cardiac rehabilitation influences serum myokine levels in patients after acute coronary syndrome: the randomised CARDIO-REH study. Sci Rep. 2025;15(1):38951. doi:10.1038/s41598-025-22897-0
Damay VA, Setiawan S, Lesmana R, Akbar MR, Lukito AA. Effects of moderate-intensity aerobic exercise on FSTL-1 regulation in atherosclerosis: a systematic review. Int J Angiol. 2023;32(1):1-10. doi:10. 1055/s-0042-1750184
Esmaeili M, Vettukattil R. Exercise intensity and cardiac metabolic adaptations in elderly heart failure rehabilitation: a review. Int J Cardiol Cardiovasc Risk Prev. 2025;27:200525. doi:10.1016/j.ijcrp.2025.200525
Yang M, Liu C, Jiang N, et al. Myostatin: a potential therapeutic target for metabolic syndrome. Front Endocrinol (Lausanne). 2023;14:1181913. doi:10.3389/fendo.2023.1181913
Lenk K, Erbs S, Höllriegel R, et al. Exercise training leads to a reduction of elevated myostatin levels in patients with chronic heart failure. Eur J Prev Cardiol. 2012;19(3):404-411. doi:10.1177/1741826711402735
Ramirez-Velez R, Gonzalez A, Garcia-Hermoso A, Amezqueta IL, Izquierdo M, Diez J. Revisiting skeletal myopathy and exercise training in heart failure: emerging role of myokines. Metabolism. 2023;138: 155348. doi:10.1016/j.metabol.2022.155348
Lyu JX, Guo DD, Song YC, et al. Circulating myokines as novel biomarkers for cardiovascular diseases. Rev Cardiovasc Med. 2024;25(2): 56.
Mińko A, Turoń-Skrzypińska A, Rył A, Mańkowska K, Cymbaluk-Płoska A, Rotter I. The significance of selected myokines in predicting the length of rehabilitation of patients after COVID-19 infection. Biomedicines. 2024;12(4):836. doi:10.3390/biomedicines12040836
Luo C, Li L, Hou L, Shi F. Effects of tiered cardiac rehabilitation on CRP, TNF-α, and physical endurance in older adults with coronary heart disease. Open Life Sci. 2025;20(1):20221040.
Pedersen BK, Fischer CP. Beneficial health effects of exercise-the role of IL-6 as a myokine. Trends Pharmacol Sci. 2007;28(4):152-156. doi:10. 1016/j.tips.2007.02.002
Tero-Vescan A, Degens H, Matsakas A, et al. Exercise-induced muscle-fat crosstalk: molecular mediators and their pharmacological modulation for the maintenance of metabolic flexibility in aging. Pharmaceuticals (Basel). 2025;18(8):1222. doi:10.3390/ph18081222
Leal LG, Lopes MA, Batista ML Jr. Physical exercise-induced myokines and muscle-adipose tissue crosstalk: a review of current knowledge and the implications for health and metabolic diseases. Front Physiol. 2018;9: 1307. doi:10.3389/fphys.2018.01307
Shakoor H, Kizhakkayil J, Statsenko Y, Platat C. Separate and combined effects of moderate-intensity exercise training and detraining with protocatechuic acid on myokines and insulin-signaling pathways in male Wistar rats: a preclinical randomized study. Metabolites. 2025; 15(2):87. doi:10.3390/metabo15020087
Rodríguez A, Becerril S, Ezquerro S, Méndez-Giménez L, Frühbeck G. Crosstalk between adipokines and myokines in fat browning. Acta Physiol (Oxf). 2017;219(2):362-381. doi:10.1111/apha.12686
Villamil-Parra W, Moscoso-Loaiza L. Effects of physical exercise on irisin and BDNF in metabolic syndrome. Exp Gerontol. 2024;198:112640. doi:10.1016/j.exger.2024.112640
Sanchis-Gomar F, Perez-Quilis C. The p38-PGC-1α-irisin-betatrophin axis: exploring new pathways in insulin resistance. Adipocyte. 2014;3(1): 67-68. doi:10.4161/adip.26709
Kour H, Sharma H. Exercise-induced myokines: molecular mechanisms and systemic health benefits. Indian J Clin Anat Physiol. 2025;12(3):101-106.
McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature. 1997;387:83-90. doi:10.1038/387083a0
Baig MH, Ahmad K, Moon JS, et al. Myostatin and its regulation: a comprehensive review of myostatin inhibiting strategies. Front Physiol. 2022;13:876078. doi:10.3389/fphys.2022.876078
Rodgers BD, Ward CW. Myostatin/activin receptor ligands in muscle and the development status of attenuating drugs. Endocr Rev. 2022;43(2): 329-365. doi:10.1210/endrev/bnab030
Stefanetti RJ, Voisin S, Russell A, Lamon S. Recent advances in understanding the role of FOXO3. F1000Res. 2018;7:F1000 Faculty Rev-1372. doi:10.12688/f1000research.15258.1
Braun T, Gautel M. Transcriptional mechanisms regulating skeletal muscle differentiation, growth and homeostasis. Nat Rev Mol Cell Biol. 2011;12(6):349-361. doi:10.1038/nrm3118
George I, Bish LT, Kamalakkannan G, et al. Myostatin activation in patients with advanced heart failure and after mechanical unloading. Eur J Heart Fail. 2010;12(5):444-453. doi:10.1093/eurjhf/hfq039
Siff T, Parajuli P, Razzaque MS, Atfi A. Cancer-mediated muscle cachexia: etiology and clinical management. Trends Endocrinol Metab. 2021;32(6):382-402. doi:10.1016/j.tem.2021.03.007
Heineke J, Auger-Messier M, Xu J, et al. Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure. Circulation. 2010;121(3):419-425. doi:10.1161/CIRCULATIONAHA.109.882068
Han HQ, Zhou X, Mitch WE, Goldberg AL. Myostatin/activin pathway antagonism: molecular basis and therapeutic potential. Int J Biochem Cell Biol. 2013;45(10):2333-2347. doi:10.1016/j.biocel.2013.05.019
McPherron AC. The ups and downs of exercise and insulin sensitivity: a role for the myokine myostatin in glucose metabolism? Acta Physiol (Oxf). 2016;217(1):6-10. doi:10.1111/apha.12635
Chung HS, Choi KM. Exercise, exerkines, and sarcopenia. Diabetes Metab J. 2026;50(1):19.
Quinn LS, Anderson BG, Strait-Bodey L, Stroud AM, Argilés JM. Oversecretion of interleukin-15 from skeletal muscle reduces adiposity. Am J Physiol Endocrinol Metab. 2009;296(1):E191-E202. doi:10.1152/ajpendo.90506.2008
Kharitonenkov A, Wroblewski VJ, Koester A, et al. The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. Endocrinology. 2007;148(2):774-781. doi:10.1210/en.2006-1168
Schlein C, Talukdar S, Heine M, et al. FGF21 lowers plasma triglycerides by accelerating lipoprotein catabolism in white and brown adipose tissues. Cell Metab. 2016;23(3):441-453. doi:10.1016/j.cmet.2016.01.006
Dutchak PA, Katafuchi T, Bookout AL, et al. Fibroblast growth factor-21 regulates PPARγ activity and the antidiabetic actions of thiazolidinediones. Cell. 2012;148(3):556-567. doi:10.1016/j.cell.2011.11. 062
Schreuder TC, Marsman HA, Lenicek M, et al. The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance. Am J Physiol Gastrointest Liver Physiol. 2010;298(3):G440-G445. doi:10.1152/ajpgi.00322.2009
Yu Y, Chen K. Peripheral immune and metabolic regulation of Aβ and Tau by exercise in Alzheimer’s disease. Front Immunol. 2025;16:1678526. doi:10.3389/fimmu.2025.1678526
Szűcs G, Pipicz M, Szabó MR, Csont T, Török L, Csonka C. Effect of eccentric exercise on metabolic health in diabetes and obesity. Sports Med Open. 2023;9(1):91. doi:10.1186/s40798-023-00636-7
Feng J, Wang X, Lu Y, Yu C, Wang X, Feng L. BAIBA involves in hypoxic training-induced browning of white adipose tissue in obese rats. Front Physiol. 2022;13:882151. doi:10.3389/fphys.2022.882151
Jung TW, Hwang HJ, Hong HC, Yoo HJ, Baik SH, Choi KM. BAIBA attenuates insulin resistance and inflammation induced by palmitate or a high-fat diet via an AMPK-PPARδ-dependent pathway in mice. Diabetologia. 2015;58(9):2096-2105. doi:10.1007/s00125-015-3663-z
Rouholamini FS, Aminaei M, Aminizadeh S. Effect of eight weeks of endurance training and MitoQ supplementation on antioxidant capacity and the expression of sestrin-2 and AMPK in cardiac tissue of aged rats. Exp Gerontol. 2024;196:112572. doi:10.1016/j.exger.2024.112572
Seo K, Ki SH, Shin SM. Sestrin2-AMPK activation protects mitochondrial function against glucose deprivation-induced cytotoxicity. Cell Signal. 2015;27(7):1533-1543. doi:10.1016/j.cellsig.2015.04.001
Ho TK, Shiwen X, Abraham D, Tsui J, Baker D. Stromal cell-derived factor-1 (SDF-1)/CXCL12 as potential target of therapeutic angiogenesis in critical leg ischaemia. Cardiol Res Pract. 2012;2012:143209. doi:10. 1155/2012/143209
Petit I, Jin D, Rafii S. The SDF-1–CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. Trends Immunol. 2007;28(7):299-307. doi:10.1016/j.it.2007.05.007
Yoshida T, Delafontaine P. Mechanisms of IGF-1-mediated regulation of skeletal muscle hypertrophy and atrophy. Cells. 2020;9(9):1970. doi:10. 3390/cells9091970
Wang J, Zhu Q, Cao D, et al. Bone marrow-derived IGF-1 orchestrates maintenance and regeneration of the adult skeleton. Proc Natl Acad Sci U S A. 2023;120(1):e2203779120. doi:10.1073/pnas.2203779120
Baghy K, Szakadáti H, Kovalszky I. Decorin the antifibrotic proteoglycan and its progression in therapy. Am J Physiol Cell Physiol. 2025;328(6): C1853-C1865.
Dong Y, Zhong J, Dong L. The role of decorin in autoimmune and inflammatory diseases. J Immunol Res. 2022;2022:1283383. doi:10.1155/ 2022/1283383
Bansal P, Kajal, Sharma S, Mazumder A. Role of BMP-7 in cardiovascular diseases: from molecular mechanisms to therapeutic horizons. Curr Drug Targets. 2025. In press.
Smith C, du Toit R, Ollewagen T. Potential of bone morphogenetic protein-7 in treatment of lupus nephritis: addressing the hurdles to implementation. Inflammopharmacology. 2023;31(5):2161-2172. doi:10. 1007/s10787-023-01279-0
Aoi W, Hirano N, Lassiter DG, et al. Secreted protein acidic and rich in cysteine (SPARC) improves glucose tolerance via AMP-activated protein kinase activation. FASEB J. 2019;33(9):10551-10562. doi:10.1096/fj.201900822R
Park SY, Hwang BO, Song NY. The role of myokines in cancer: crosstalk between skeletal muscle and tumor. BMB Rep. 2023;56(7):365-373. doi: 10.5483/BMBRep.2023-0099

Details

Primary Language

English

Subjects

Clinical Chemistry

Journal Section

Review

Authors

Elif Zeynep Öztürk ^*
0000-0002-8741-2766
Türkiye

Mehlika Alataş
0000-0002-7703-9312
Türkiye

Publication Date

May 19, 2026

Submission Date

February 5, 2026

Acceptance Date

April 17, 2026

Published in Issue

Year 2026 Volume: 9 Number: 3

DOI

https://doi.org/10.32322/jhsm.1883007

IZ

https://izlik.org/JA73MN49KF

Cite

RIS / Bibtex

APA

Öztürk, E. Z., & Alataş, M. (2026). Effects of exercise-induced myokines on rehabilitation and metabolic regulation. Journal of Health Sciences and Medicine, 9(3), 846-851. https://doi.org/10.32322/jhsm.1883007

AMA

1.Öztürk EZ, Alataş M. Effects of exercise-induced myokines on rehabilitation and metabolic regulation. J Health Sci Med / JHSM. 2026;9(3):846-851. doi:10.32322/jhsm.1883007

Chicago

Öztürk, Elif Zeynep, and Mehlika Alataş. 2026. “Effects of Exercise-Induced Myokines on Rehabilitation and Metabolic Regulation”. Journal of Health Sciences and Medicine 9 (3): 846-51. https://doi.org/10.32322/jhsm.1883007.

EndNote

Öztürk EZ, Alataş M (May 1, 2026) Effects of exercise-induced myokines on rehabilitation and metabolic regulation. Journal of Health Sciences and Medicine 9 3 846–851.

IEEE

[1]E. Z. Öztürk and M. Alataş, “Effects of exercise-induced myokines on rehabilitation and metabolic regulation”, J Health Sci Med / JHSM, vol. 9, no. 3, pp. 846–851, May 2026, doi: 10.32322/jhsm.1883007.

ISNAD

Öztürk, Elif Zeynep - Alataş, Mehlika. “Effects of Exercise-Induced Myokines on Rehabilitation and Metabolic Regulation”. Journal of Health Sciences and Medicine 9/3 (May 1, 2026): 846-851. https://doi.org/10.32322/jhsm.1883007.

JAMA

1.Öztürk EZ, Alataş M. Effects of exercise-induced myokines on rehabilitation and metabolic regulation. J Health Sci Med / JHSM. 2026;9:846–851.

MLA

Öztürk, Elif Zeynep, and Mehlika Alataş. “Effects of Exercise-Induced Myokines on Rehabilitation and Metabolic Regulation”. Journal of Health Sciences and Medicine, vol. 9, no. 3, May 2026, pp. 846-51, doi:10.32322/jhsm.1883007.

Vancouver

1.Elif Zeynep Öztürk, Mehlika Alataş. Effects of exercise-induced myokines on rehabilitation and metabolic regulation. J Health Sci Med / JHSM. 2026 May 1;9(3):846-51. doi:10.32322/jhsm.1883007